Abbreviations
- MCLS:
-
mucocutaneous lymph node syndrome
- SCD8:
-
soluble from of CD8
- sIL-2R:
-
soluble interleukin-2-receptor
References
Fujimoto J, Levy S, Levy R (1983) Spontaneous release of the Leu-2 (T8) molecule from human T cells. J Exp Med 59:752–766
Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, Koto H, Yabuta K (1988) Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 48:247–251
Leung DYM, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, Pober JS (1986) Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 164:1958–1972
Maury CPJ, Salo E, Pelkonen P (1988) Circulating interleukin-1 in patients with Kawasaki disease. N Engl J Med 395:1670–1671
Pui C-H, Ip SH, Dodge RK, Carrabis S, Brown M, Crist WM, Berard CW, Kung P, Dahl GV, Murphy SB (1988) Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients. Blood 72:1015–1021
Scollard DM, Wagner DK, Nelson DL (1988) Release of soluble interleukin-2 receptors (Tac peptide) in vivo during human immune responses to tuberculin. Clin Immunol Immunopathol 46:450–455
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Furumoto, H., Sakano, T., Tanabe, A. et al. Serum soluble CD8 antigen level is not elevated in mucocutaneous lymph node syndrome (Kawasaki disease) in spite of an increase in serum soluble interleukin 2 receptors. Eur J Pediatr 149, 448–449 (1990). https://doi.org/10.1007/BF02009673
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02009673